OMEGA HEALTHCARE INVESTORS INC
For the period ended Sep 30, 2025. Filed Oct 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 31, 2025
OHI$48.70-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Unaudited (in thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| | Nine Months Ended September 30, | |||||
| · 2025 · 2024 | ||||||
| Cash flows from operating activities · · | ||||||
| Net income | | $437,495 | | $301,339 | ||
| Adjustment to reconcile net income to net cash provided by operating activities: | | | | |||
| Depreciation and amortization | | 242,498 | | 226,036 | ||
| Impairment on real estate properties | | 16,594 | | 22,094 | ||
| Straight-line rent and other write-offs | | | 27,537 | | | 1,136 |
| Recovery for credit losses | | (3,587) | | (14,763) | ||
| Amortization of deferred financing costs and loss on debt extinguishment | | 3,458 | | 10,584 | ||
| Stock-based compensation expense | | 34,323 | | 27,498 | ||
| Gain on assets sold – net | | (61,230) | | (11,282) | ||
| Straight-line rent and effective interest receivables | | (36,944) | | (29,298) | ||
| Interest paid-in-kind | | | (9,346) | | | (9,043) |
| Loss (income) from unconsolidated entities | | | 5,688 | | | (4,331) |
| Other non-cash items | | (10,534) | | (2,231) | ||
| Change in operating assets and liabilities – net: | | | | |||
| Contractual receivables | | 53 | | 1,429 | ||
| Lease inducements | | (9,269) | | 699 | ||
| Other operating assets and liabilities | | 11,195 | | 595 | ||
| Net cash provided by operating activities | | 647,931 | | 520,462 | ||
| Cash flows from investing activities | | | | | ||
| Acquisition of real estate | | (627,844) | | (229,803) | ||
| Net proceeds from sale of real estate investments | | 264,061 | | 68,757 | ||
| Investments in construction in progress | | (31,479) | | (59,292) | ||
| Investment in loan receivables and other | | (140,882) | | (272,889) | ||
| Collection of loan principal | | 120,357 | | 113,552 | ||
| Investments in unconsolidated entities | | | (77,244) | | | (398) |
| Distributions from unconsolidated entities in excess of earnings | | 9,969 | | 2,835 | ||
| Capital improvements to real estate investments | | (54,176) | | (22,278) | ||
| Proceeds from derivative instruments | | 4,675 | | 8,429 | ||
| Receipts from insurance proceeds | | 4,478 | | 1,657 | ||
| Net cash used in investing activities | | (528,085) | | (389,430) | ||
| Cash flows from financing activities | | | ||||
| Proceeds from long-term borrowings | | 670,708 | | 657,819 | ||
| Payments of long-term borrowings | | (528,496) | | (1,142,788) | ||
| Payments of financing related costs | | (25,600) | | (6,903) | ||
| Net proceeds from issuance of common stock | | 606,810 | | 801,223 | ||
| Dividends paid | | (581,996) | | (503,998) | ||
| Net payments to noncontrolling members of consolidated joint venture | | — | | 545 | ||
| Redemption of Omega OP Units | | | (5,768) | | | — |
| Distributions to Omega OP Unit Holders | | (33,451) | | (22,988) | ||
| Net cash provided by (used in) financing activities | | 102,207 | | (217,090) | ||
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | | 4,216 | | 1,638 | ||
| Increase (decrease) in cash, cash equivalents and restricted cash | | 226,269 | | (84,420) | ||
| Cash, cash equivalents and restricted cash at beginning of period | | 548,735 | | 444,730 | ||
| Cash, cash equivalents and restricted cash at end of period | | $775,004 | | $360,310 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.